Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL retains the right to collect royalties...

My guess is that DMP may have requested this type of 'royalty' payment.. Begin with a relatively low initial payment, and then if the patents are rendered invalid, they would not have to pay any additional, and are only out their smaller initial payment. Of course hopefully the patents are strengthened with litigation/USPTO and DMP (along with all the rest) will pay the remainder of what they owe for infringement and future use.

jmo

Share
New Message
Please login to post a reply